New paper in JAMA Neurology: Assessing Biological and Methodological Aspects of Brain Volume Loss in Multiple Sclerosis
Brain volume loss is a promising marker of therapeutic response in multiple sclerosis (MS). The MS visual pathway group leaded by E. H. Martinez-Lapiscina recently published in JAMA Neurology a study that aimed to assess the dynamics of this parameter as MS progresses by using different imaging methods.
We found out that brain volume loss rates were higher in the first 5 years after MS onset with a direct association with steroids and an inverse association with age. To conclude, it seems that proposed brain volume loss threshold of less than 0.4% per year should be reconsidered in future studies.
MISSION EUPON inspires European multidisciplinary collaborations to further the knowledge in ophthalmological and neurological optic nerve pathologies. VISION To be a European reference and lead international efforts in diagnostic, therapeutic and research strategies involving optic nerve. TARGET AUDIENCE Opthalmologist, Neurologist, Engineers working in Biomedicine, Optometrists, Nurses
By Analía Bortolozzi, PhD. IDIBAPS Researcher.
Área de Neurociències clíniques i experimentals